BioLife Solutions Inc. vs. Nexalin Technology, Inc. Common Stock
BLFS
BioLife Solutions Inc.
$39.59 +2.86%
VS NXLNexalin Technology, Inc. Common Stock
$5.65 -25.17%
BioLife Solutions Inc. (BLFS) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BLFS | NXL | |
|---|---|---|
| Market Cap | $1.88 billion | $6.26 million |
| Revenue (TTM) | $102.82 million | — |
| Net Income (TTM) | $57.98 million | — |
BLFS leads on 1 of 1 size & scale factors.
Valuation
| BLFS | NXL | |
|---|---|---|
| P/E Ratio | 33.84 | — |
| Price / Book | 4.48 | — |
| Price / Sales | 18.31 | — |
BLFS and NXL split the valuation factors evenly.
Profitability
| BLFS | NXL | |
|---|---|---|
| Net Margin | 56.39% | — |
| Return on Equity | 13.80% | — |
BLFS and NXL split the profitability factors evenly.
Dividend
| BLFS | NXL | |
|---|---|---|
| Dividend Yield | — | 22.12% |
BLFS and NXL split the dividend factors evenly.
Risk & Sentiment
| BLFS | NXL | |
|---|---|---|
| Short Interest | 1.61% | 2.34% |
BLFS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLFS overview, BLFS financials, NXL overview, NXL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.